Medicover Genetics delivers integrated genomic diagnostics and laboratory enablement solutions worldwide, advancing precision medicine in oncology, reproductive health, rare diseases, and pharmacogenomics. With 25+ years of clinical genomics expertise, CAP-, CLIA- and ISO 15189-accredited labs across Europe, and in-house R&D in precision oncology and liquid biopsy/MRD, we bring validated technologies from our own laboratories into everyday clinical practice.
Medicover Genetics is part of Medicover, a leading international healthcare and diagnostics provider headquartered in Sweden and listed on Nasdaq Stockholm. For more information about Medicover, visit .
Our solutions
We provide a comprehensive range of genetic testing services to support healthcare professionals in choosing the right test for every patient. From cytogenetic analyses and molecular pathology to cutting-edge Next Generation Sequencing (NGS) and microbiome testing, all solutions are developed in-house at our laboratories in Germany and Cyprus and delivered worldwide.
Beyond testing, we empower laboratories of any size with CE-IVD kits and technology transfer, including our proprietary workflows for non-invasive prenatal tests (VERACITY and VERAgene) and TarCET IVD kits for streamlined NGS-based diagnostics.
Whether you’re a healthcare provider or a lab partner, we deliver end-to-end solutions designed for accuracy, reliability, and impact.

Accredited laboratories
Our accredited laboratories operate under the most rigorous international quality standards in genetic diagnostics. These accreditations are the foundation of the trust we build with clinicians, hospital partners, and patients across more than 60 countries.






